This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Auspex Pharmaceuticals, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Sandeep Pandita: Innovator in Osmotic Dosage Forms
Introduction
Sandeep Pandita is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of osmotic dosage forms.
Latest Patents
Sandeep holds a patent for "Osmotic dosage forms comprising deutetrabenazine and methods of use thereof." This innovative patent provides osmotic dosage forms containing deutetrabenazine for the treatment of hyperkinetic movement disorders. When administered orally on a once-daily basis, these dosage forms demonstrate a favorable pharmacokinetic profile for the active agent, indicating treatment efficacy over an extended period.
Career Highlights
Sandeep is currently associated with Auspex Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that enhance patient care.
Collaborations
Some of his notable coworkers include Parag Shah and Mayank Joshi, who contribute to the collaborative environment at Auspex Pharmaceuticals, Inc.
Conclusion
Sandeep Pandita's innovative work in osmotic dosage forms exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions are paving the way for improved treatment options for patients with movement disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile